Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Dec;2(12):e502-3.
doi: 10.1016/S2352-3018(15)00224-6. Epub 2015 Nov 6.

Uptake and effectiveness of PrEP for transgender women

Brandon D L Marshall  1 , Matthew J Mimiaga  2
Affiliations
Comment

Uptake and effectiveness of PrEP for transgender women

Brandon D L Marshall et al. Lancet HIV. 2015 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:214–22. - PubMed
    1. Operario D, Nemoto T. HIV in transgender communities: syndemic dynamics and a need for multicomponent interventions. J Acquir Immune Defic Syndr. 2010;55(suppl 2):S91–93. - PMC - PubMed
    1. Escudero DJ, Kerr T, Operario D, Socias ME, Sued O, Marshall BDL. Inclusion of trans women in pre-exposure prophylaxis trials: a review. AIDS Care. 2015;27:637–41. - PMC - PubMed
    1. Deutsch MB, Glidden DV, Sevelius J, et al. for the iPrEx investigators. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 published online Nov 5. http://dx.doi.org/10.1016/S2352-3018(15)00206-4. - DOI - PMC - PubMed
    1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99. - PMC - PubMed

Substances